MLAB
Mesa Laboratories Inc
NASDAQ: MLAB · TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS
$100.00
+4.43% today
Updated 2026-04-30
Market cap
$542.98M
P/E ratio
151.20
P/S ratio
2.19x
EPS (TTM)
$0.65
Dividend yield
0.65%
52W range
$55 – $130
Volume
0.1M
Mesa Laboratories Inc (MLAB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
1.51%
Operating margin
12.20%
ROE
2.18%
ROA
2.47%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $11.58M | $2.81M | 64.21% | 35.48% | 24.22% |
| 2007 | $17.24M | $3.96M | 63.19% | 32.82% | 22.96% |
| 2008 | $19.56M | $4.61M | 65.74% | 36.10% | 23.57% |
| 2009 | $21.54M | $4.79M | 64.16% | 35.33% | 22.24% |
| 2010 | $21.93M | $4.77M | 60.17% | 33.60% | 21.75% |
| 2011 | $32.83M | $6.18M | 59.61% | 30.05% | 18.84% |
| 2012 | $39.62M | $7.92M | 59.35% | 31.49% | 19.99% |
| 2013 | $46.44M | $8.45M | 62.16% | 28.22% | 18.20% |
| 2014 | $52.72M | $9.00M | 60.10% | 22.35% | 17.07% |
| 2015 | $71.33M | $9.58M | 60.83% | 22.24% | 13.43% |
| 2016 | $84.66M | $11.17M | 60.73% | 19.28% | 13.19% |
| 2017 | $93.67M | $11.18M | 56.84% | 17.42% | 11.94% |
| 2018 | $96.18M | $-2.96M | 56.79% | 2.27% | -3.08% |
| 2019 | $103.14M | $7.48M | 59.06% | 9.48% | 7.26% |
| 2020 | $117.69M | $1.78M | 55.54% | 6.73% | 1.51% |
| 2021 | $133.94M | $3.27M | 64.97% | 9.23% | 2.44% |
| 2022 | $184.34M | $1.87M | 59.18% | 2.55% | 1.01% |
| 2023 | $219.08M | $930000.00 | 61.02% | 1.52% | 0.42% |
| 2024 | $216.19M | $-254.25M | 61.64% | -125.85% | -117.60% |
| 2025 | $240.98M | $-1.97M | 62.61% | 6.78% | -0.82% |